Pulmonary Arterial Hypertension in the Elderly-Clinical Characteristics and Long-Term Survival

[1] McLaughlin VV(2009)ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation task force on expert consensus documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association J Am Coll Cardiol 53 1573-1619

[2] Archer SL(2009)Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 S43-S54

[3] Badesch DB(2010)Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature Respir Med 104 1588-1607

[4] Barst RJ(2009)ESC committee for practice guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2493-2537

[5] Farber HW(2010)Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry Chest 137 376-387

[6] Lindner JR(2006)Pulmonary arterial hypertension in France: results from a national registry Am J Respir Crit Care Med 173 1023-1030

[7] Mathier MA(2007)Unexplained pulmonary hypertension in elderly patients Chest 131 94-100

[8] McGoon MD(2010)Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL) Circulation 122 164-172

[9] Park MH(2010)Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era Circulation 122 156-163

[10] Rosenson RS(2011)Prevalence and impact of coronary artery disease in patients with pulmonary arterial hypertension Am J Cardiol 108 460-464

[1] McLaughlin VV(2009)ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation task force on expert consensus documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association J Am Coll Cardiol 53 1573-1619

[2] Archer SL(2009)Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 S43-S54

[3] Badesch DB(2010)Factors that prognosticate mortality in idiopathic pulmonary arterial hypertension: a systematic review of the literature Respir Med 104 1588-1607

[4] Barst RJ(2009)ESC committee for practice guidelines (CPG). Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2493-2537

[5] Farber HW(2010)Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry Chest 137 376-387

[6] Lindner JR(2006)Pulmonary arterial hypertension in France: results from a national registry Am J Respir Crit Care Med 173 1023-1030

[7] Mathier MA(2007)Unexplained pulmonary hypertension in elderly patients Chest 131 94-100

[8] McGoon MD(2010)Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL) Circulation 122 164-172

[9] Park MH(2010)Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era Circulation 122 156-163

[10] Rosenson RS(2011)Prevalence and impact of coronary artery disease in patients with pulmonary arterial hypertension Am J Cardiol 108 460-464